1
/
of
0
FDA Drug/Biologics Approval BLA 761127, DAXIBOTULINUMTOXINA-LANM
FDA Drug/Biologics Approval BLA 761127, DAXIBOTULINUMTOXINA-LANM
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
BLA 761127
Company: REVANCE THERAPEUTICS, INC.
Drug Name: DAXXIFY
Active Ingredients: DAXIBOTULINUMTOXINA-LANM
Strength: 0.1ML
Dosage Form/Route: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
Action Date: 09/07/2022
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: REVANCE THERAPEUTICS, INC.
Drug Name: DAXXIFY
Active Ingredients: DAXIBOTULINUMTOXINA-LANM
Strength: 0.1ML
Dosage Form/Route: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
Action Date: 09/07/2022
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details